Immune Pharmaceuticals/ US45254C2008 /
2022-08-16 8:46:55 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.0010USD | - | 1,500 Turnover: 1.5000 |
-Bid Size: - | -Ask Size: - | 0.0010 | 0.0010 |
GlobeNewswire
2021-09-01
Brickell Biotech Expands Leadership Team, Appointing Dr. Monica Luchi as Chief Medical Officer
GlobeNewswire
2020-06-16
Mr. Robert W. Cook, Seasoned Biotech Executive, Joins RenovaCare as Chief Financial Officer and Boar...
Newsfile Corp
2019-11-25
Alexion Pharmaceuticals - iCo's New Partner for the Development and Commercialization of iCo-008
Newsfile Corp
2019-10-28
Monoclonal Antibodies; A Growing Sector of the Bio/Pharma Industry and How Smaller Players are Findi...
GlobeNewswire
2019-10-14
Innovation Pharmaceuticals Partnering Provides Momentum For Inflammatory Bowel Disease Programs, Tar...
GlobeNewswire
2019-07-22
Innovation Pharmaceuticals Announces License Agreement with Alfasigma S.p.A. for the Development and...
GlobeNewswire
2019-06-06
Innovation Pharmaceuticals Signs Agreement for Advanced Oral Tablet Technology in Treating Inflammat...
GlobeNewswire
2019-01-30
Kamada Appoints Senior Biopharmaceutical Executive Michal Ayalon, Ph.D., as Vice President of Resear...
GlobeNewswire
2019-01-22
Innovation Pharmaceuticals Announces Clinical Development Plans for Oral Brilacidin for Inflammatory...
GlobeNewswire
2018-12-18
Immune Pharmaceuticals Engages Extera Partners to Pursue Bertilimumab Strategic Transaction
GlobeNewswire
2018-12-06
UPDATE -- Immune Pharmaceuticals Announces Adjournment of Special Meeting of Stockholders
GlobeNewswire
2018-12-06
Immune Pharmaceuticals Announces Adjournment of Special Meeting of Stockholders
GlobeNewswire
2018-09-25
Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2025 - Focus on Marketed, Clin...
GlobeNewswire
2018-09-11
Bertilimumab Granted Fast Track Designation for the Treatment of Bullous Pemphigoid
GlobeNewswire
2018-08-20
Bertilimumab Granted Orphan Drug Designation for the Treatment of Bullous Pemphigoid
GlobeNewswire
2018-07-30
Immune Pharmaceuticals Receives Positive Opinion for Orphan Drug Designation in the European Union f...
GlobeNewswire
2018-07-26
Immune Pharmaceuticals Receives Nasdaq Delisting Determination; Eligible to trade Over-the-Counter J...
GlobeNewswire
2018-07-17
Immune Pharmaceuticals Announces Filing of Proxy Statement for Reverse Stock Split